ICER’s Patient Council
In 2023, ICER announced the creation of a Patient Council to advise on ICER’s patient engagement strategy, outreach, and process for input into drug reviews and broader initiatives. The Council comprises several patient representatives with a range of expertise on health technology assessment (HTA) and engaging with ICER, offering a variety of perspectives for evaluation of the ICER process.
The objective of the Patient Council is to help patients and the public understand the value and impact of their involvement, and improve the diversity of people that are included in the process of the evaluation of health treatments.
1. Evaluate current process of patient engagement to identify gaps and opportunities for improved communication and participation.
2. Ensure that the HTA process is inclusive of a diversity of experiences.
3. Review ICER’s Patient Portal and any future public facing documents to ensure accessibility and inclusivity.
ICER’s Patient Council
Tiffany Westrich-Robertson
ICER Patient Council Co-Chair; CEO, International Foundation for Autoimmune & Autoinflammatory Arthritis (AiArthritis)
Dina Thachet
Board Member and Patient Advocate, Lupus and Allied Diseases Association (LADA)
Isiah C. Lineberry
Former Executive Director, Harrisburg Family Health Care
Rev. Tammie Denyse
Cofounder & President, Carrie’s TOUCH Breast Cancer Organization
Richard Pezzillo
Executive Director, New England Hemophilia Association
Patient Council members are participating as individuals, and are not representing the views of their affiliated organizations.